<DOC>
	<DOCNO>NCT02468284</DOCNO>
	<brief_summary>The purpose trial look much new trial drug get body , drug concentration body reach peak high peak value .</brief_summary>
	<brief_title>Pharmacokinetics Degarelix Chinese Patients With Prostate Cancer</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<criteria>Has histologically confirm ( Gleason grade ) adenocarcinoma prostate ( stage ) , endocrine therapy ( except neoadjuvant hormonal therapy ) indicate Has Prostatespecific Antigen ( PSA ) level ≥2.0 ng/mL Screening Has screen serum testosterone level &gt; 150 ng/dL Has Eastern Cooperative Oncology Group ( ECOG ) score ≤2 Has previous currently hormonal management prostate cancer . However , hormonal therapy maximum duration 6 month accept . This treatment terminate least 6 month prior Screening Visit Is currently treat 5alpha reductase inhibitor Is consider candidate curative therapy , i.e . radical prostatectomy radiotherapy Is need neoadjuvant hormonal therapy Has history bilateral orchiectomy , adrenalectomy , hypophysectomy</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>